|
1
|
Bichat clinical guidelines for bioterrorist agents.
|
Euro Surveill
|
2004
|
1.54
|
|
2
|
Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses.
|
Euro Surveill
|
2004
|
1.29
|
|
3
|
Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis.
|
Euro Surveill
|
2004
|
1.10
|
|
4
|
Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis.
|
Euro Surveill
|
2004
|
0.98
|
|
5
|
Bichat guidelines for the clinical management of plague and bioterrorism-related plague.
|
Euro Surveill
|
2004
|
0.88
|
|
6
|
Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax.
|
Euro Surveill
|
2004
|
0.87
|
|
7
|
Bichat guidelines for the clinical management of Q fever and bioterrorism-related Q fever.
|
Euro Surveill
|
2004
|
0.86
|
|
8
|
Bichat guidelines for the clinical management of botulism and bioterrorism-related botulism.
|
Euro Surveill
|
2004
|
0.78
|
|
9
|
Bichat guidelines for the clinical management of smallpox and bioterrorism-related smallpox.
|
Euro Surveill
|
2004
|
0.76
|